Articles Tagged With: FDA
-
FDA responds on needle ban, standards, labeling
-
FDA says it’s needlestuck without more sharps data
-
Pharmacology Watch: FDA - No Approval for Pleconaril; Side Effects Cited
-
Mifepristone approval delayed, supporters look to action by FDA
-
FDA action may clear way for more reprocessing
-
FDA policy on reprocessing not for surgery centers
-
FDA Ruling on Mitoxantrone for Multiple Sclerosis
-
FDA moves to toughen hospital reuse policies
-
FDA adds to momentum to limit use of powdered latex gloves in hospitals